Hyundai Bioscience

048410.KQ

10.22 USD

-0.18

-1.73%

Overview

Last close

10.22 usd

Market cap

431.94M usd

52 week high

27.33 usd

52 week low

8.63 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

68.3327

Price/Book Value

14.4734

Enterprise Value

453.73M usd

EV/Revenue

41.1149

EV/EBITDA

-64.6317

Key financials

Revenue TTM

6.45M usd

Gross Profit TTM

2.85M usd

EBITDA TTM

-5.09M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

76.53M usd

Net debt

N/A usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.